Cargando…

Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles

The objective of this study was to investigate the use of cationized Pleurotus eryngii polysaccharide (CPEPS) as a nonviral gene delivery vehicle to transfer plasmid DNA encoding transforming growth factor beta-1 (pTGF-β1) into mesenchymal stem cells (MSCs) in vitro. Crude P. eryngii polysaccharide...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Wen Wen, Cao, Xia, Wang, Miao, Qu, Rui, Su, Wei Yan, Yang, Yan, Wei, Ya Wei, Xu, Xi Ming, Yu, Jiang Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310408/
https://www.ncbi.nlm.nih.gov/pubmed/22457592
http://dx.doi.org/10.2147/IJN.S28010
_version_ 1782227642255147008
author Deng, Wen Wen
Cao, Xia
Wang, Miao
Qu, Rui
Su, Wei Yan
Yang, Yan
Wei, Ya Wei
Xu, Xi Ming
Yu, Jiang Nan
author_facet Deng, Wen Wen
Cao, Xia
Wang, Miao
Qu, Rui
Su, Wei Yan
Yang, Yan
Wei, Ya Wei
Xu, Xi Ming
Yu, Jiang Nan
author_sort Deng, Wen Wen
collection PubMed
description The objective of this study was to investigate the use of cationized Pleurotus eryngii polysaccharide (CPEPS) as a nonviral gene delivery vehicle to transfer plasmid DNA encoding transforming growth factor beta-1 (pTGF-β1) into mesenchymal stem cells (MSCs) in vitro. Crude P. eryngii polysaccharide was purified, and then cationized by grafting spermine onto the backbone of the polysaccharide. Agarose gel electrophoresis, transmission electron microscopy, and a Nano Sense Zetasizer (Malvern Instruments, Malvern, UK) were used to characterize the CPEPS-pTGF-β1 nanoparticles. The findings of cytotoxicity analysis showed that when the nanoparticles were formulated with a CPEPS/pTGF-β1 weight ratio ≥ 10:1, a greater gel retardation effect was observed during agarose gel electrophoresis. The CPEPS-pTGF-β1 nanoparticles with a weight ratio of 20:1, respectively, possessed an average particle size of 80.8 nm in diameter and a zeta potential of +17.4 ± 0.1 mV. Significantly, these CPEPS-pTGF-β1 nanoparticles showed lower cytotoxicity and higher transfection efficiency than both polyethylenimine (25 kDa) (P = 0.006, Student’s t-test) and Lipofectamine(TM) 2000 (P = 0.002, Student’s t-test). Additionally, the messenger RNA expression level of TGF-β1 in MSCs transfected with CPEPS-pTGF-β1 nanoparticles was significantly higher than that of free plasmid DNA-transfected MSCs and slightly elevated compared with that of Lipofectamine 2000-transfected MSCs. Flow cytometry analysis demonstrated that 92.38% of MSCs were arrested in the G1 phase after being transfected with CPEPS-pTGF-β1 nanoparticles, indicating a tendency toward differentiation. In summary, the findings of this study suggest that the CPEPS-pTGF-β1 nanoparticles prepared in this work exhibited excellent transfection efficiency and low toxicity. Therefore, they could be developed into a promising nonviral vector for gene delivery in vitro.
format Online
Article
Text
id pubmed-3310408
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-33104082012-03-28 Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles Deng, Wen Wen Cao, Xia Wang, Miao Qu, Rui Su, Wei Yan Yang, Yan Wei, Ya Wei Xu, Xi Ming Yu, Jiang Nan Int J Nanomedicine Original Research The objective of this study was to investigate the use of cationized Pleurotus eryngii polysaccharide (CPEPS) as a nonviral gene delivery vehicle to transfer plasmid DNA encoding transforming growth factor beta-1 (pTGF-β1) into mesenchymal stem cells (MSCs) in vitro. Crude P. eryngii polysaccharide was purified, and then cationized by grafting spermine onto the backbone of the polysaccharide. Agarose gel electrophoresis, transmission electron microscopy, and a Nano Sense Zetasizer (Malvern Instruments, Malvern, UK) were used to characterize the CPEPS-pTGF-β1 nanoparticles. The findings of cytotoxicity analysis showed that when the nanoparticles were formulated with a CPEPS/pTGF-β1 weight ratio ≥ 10:1, a greater gel retardation effect was observed during agarose gel electrophoresis. The CPEPS-pTGF-β1 nanoparticles with a weight ratio of 20:1, respectively, possessed an average particle size of 80.8 nm in diameter and a zeta potential of +17.4 ± 0.1 mV. Significantly, these CPEPS-pTGF-β1 nanoparticles showed lower cytotoxicity and higher transfection efficiency than both polyethylenimine (25 kDa) (P = 0.006, Student’s t-test) and Lipofectamine(TM) 2000 (P = 0.002, Student’s t-test). Additionally, the messenger RNA expression level of TGF-β1 in MSCs transfected with CPEPS-pTGF-β1 nanoparticles was significantly higher than that of free plasmid DNA-transfected MSCs and slightly elevated compared with that of Lipofectamine 2000-transfected MSCs. Flow cytometry analysis demonstrated that 92.38% of MSCs were arrested in the G1 phase after being transfected with CPEPS-pTGF-β1 nanoparticles, indicating a tendency toward differentiation. In summary, the findings of this study suggest that the CPEPS-pTGF-β1 nanoparticles prepared in this work exhibited excellent transfection efficiency and low toxicity. Therefore, they could be developed into a promising nonviral vector for gene delivery in vitro. Dove Medical Press 2012 2012-03-14 /pmc/articles/PMC3310408/ /pubmed/22457592 http://dx.doi.org/10.2147/IJN.S28010 Text en © 2012 Deng et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Deng, Wen Wen
Cao, Xia
Wang, Miao
Qu, Rui
Su, Wei Yan
Yang, Yan
Wei, Ya Wei
Xu, Xi Ming
Yu, Jiang Nan
Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title_full Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title_fullStr Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title_full_unstemmed Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title_short Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles
title_sort delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized pleurotus eryngii polysaccharide nanoparticles
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310408/
https://www.ncbi.nlm.nih.gov/pubmed/22457592
http://dx.doi.org/10.2147/IJN.S28010
work_keys_str_mv AT dengwenwen deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT caoxia deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT wangmiao deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT qurui deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT suweiyan deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT yangyan deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT weiyawei deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT xuximing deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles
AT yujiangnan deliveryofatransforminggrowthfactorb1plasmidtomesenchymalstemcellsviacationizedpleurotuseryngiipolysaccharidenanoparticles